NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

NCT05059327

CompletedPhase 2

Sponsor: Noema Pharma AG

Conditions: Tuberous Sclerosis Complex

Interventions: Basimglurant with crossover to Placebo, Placebo with crossover to Basimglurant

Countries: United States, India, Israel, Italy, Poland, Spain, Turkey (Türkiye), United Kingdom

The study intends to show that basimglurant (NOE-101) provides effective seizure control in children, adolescents and young adults with Tuberous Sclerosis Complex (TSC).

Eligibility overview

Sex: ALL

Age: 5 Years to 30 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria (summary):

* Ability and willingness to provide informed assent or written consent or consent from their legal representative.
* Fluency in the language of the study staff
* Age 5 to 30 years at study entry
* A documented history of TSC
* Refractory seizure history
* Currently receiving one or more anti-epileptic drugs (AEDs)
* Stable medications or interventions for epilepsy
* Willingness to complete Patient Reported Outcome assessments
* For female patients of childbearing potential:

  1. Willingness to undergo serum or urinary pregnancy testing at screening and during the trial period.
  2. Willingness to use contraception.

Exclusion Criteria (summary):

* Neurologic disease other than TSC
* Recent anoxic episode
* Patient weight below 15kg
* Clinically significant unstable medical condition(s)
* Pregnancy or lactation
Locations (27)
  • Los Angeles, California, United States
  • Baltimore, Maryland, United States
  • Boston, Massachusetts, United States
  • Royal Oak, Michigan, United States
  • Roseville, Minnesota, United States
  • Hawthorne, New York, United States
  • Durham, North Carolina, United States
  • Cleveland, Ohio, United States
  • Houston, Texas, United States
  • Hyderabad, Andhra Pradesh, India
  • Hyderabad, Andhra Pradesh, India
  • Mumbai, Maharashtra, India
  • Pune, Maharashtra, India
  • New Delhi, National Capital Territory of Delhi, India
  • Vellore, Tamil Nadu, India
  • Jerusalem, Israel
  • Milan, Lombardy, Italy
  • Warsaw, Masovian Voivodeship, Poland
  • Badalona, Barcelona, Spain
  • Esplugues de Llobregat, Barcelona, Spain
  • Málaga, Spain
  • Seville, Spain
  • Fatih, Istanbul, Turkey (Türkiye)
  • Kadıköy, Istanbul, Turkey (Türkiye)
  • Sultangazi, Istanbul, Turkey (Türkiye)
  • Salford, Lancashire, United Kingdom
  • Cardiff, South Glamorgan, United Kingdom